HARMAN to Acquire ZF’s ADAS Business
23.12.2025 10:00:00 EET | Business Wire | Press release
HARMAN International, a global leader in automotive technology and lifestyle audio, and a wholly-owned subsidiary of Samsung Electronics Co., Ltd., today announced that it has entered into a definitive agreement to acquire the Advanced Driver Assistance Systems (ADAS) business of ZF Group, comprising leading automotive compute solutions, smart cameras, radars and ADAS software functions. The transaction is valued at €1.5 billion.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223683768/en/
Mathias Miedreich, CEO of ZF Group; Young Sohn, Chairman of the Board of Directors, HARMAN and Senior Advisor, Samsung Electronics; and Christian Sobottka, Chief Executive Officer and President, Automotive Division, HARMAN, sign a definitive agreement for HARMAN to acquire ZF’s ADAS business – strengthening HARMAN’s leadership in software-defined vehicles and advancing a unified safety-to-experience platform for automakers worldwide.
A Strategic Step toward an Integrated, Centralized Vehicle Architecture
HARMAN’s “Consumer Experiences. Automotive Grade.” strategy focuses on bringing the speed, intelligence, and intuitive experiences consumers expect from leading technology brands into vehicles, while also meeting the highest standards for automotive safety, reliability, and long-term platform support. As automakers accelerate toward software-defined vehicles (SDV), this approach enables experiences that seamlessly connect safety and assisted driving functions with comfort, connectivity, and in-vehicle intelligence. With this acquisition, HARMAN has secured strategic inroads in the ADAS and central compute platforms markets, reinforcing a foundation that anchors and advances its role in the fast-growing SDV market.
By integrating ZF’s ADAS capabilities with HARMAN's flagship Digital Cockpit offerings within a centralized compute design, the acquisition bolsters HARMAN’s roadmap for next-generation vehicle architectures. The combination creates a foundation for future central compute solutions that bring assisted and automated driving solutions, safety and user experiences on a shared platform. This approach streamlines system design, reduces integration complexity, and supports more efficient innovation cycles, allowing HARMAN to enable OEMs to scale differentiated, context-aware vehicle experiences.
“The industry is at an inflection point where safety, intelligence, and in-cabin experience must come together through a unified computing architecture,” said Christian Sobottka, Chief Executive Officer and President, Automotive Division, HARMAN. “With this agreement, we take a strategic step to expand our portfolio with complementary ADAS capabilities that unlock a new class of cross-domain experiences ranging from perception-informed audio cues to more personalized, situation-aware driving. Combined with HARMAN’s long-standing automotive expertise and supported by Samsung’s broader technology leadership, this positions us to help OEMs design the next generation of intelligent, empathetic, and connected vehicles.”
“With HARMAN, we have found the ideal partner to fully unlock the growth and innovation potential of our ADAS business,” said Mathias Miedreich, CEO of ZF Group. “At the same time, this deal makes an important contribution to reducing our company’s debt and allows us to focus our resources on the core technologies in which ZF is a global leader.”
“Samsung has a successful record of strategic acquisitions that accelerate innovation and expand what’s possible for our customers,” said Young Sohn, Chairman of the Board of Directors, HARMAN and Senior Advisor, Samsung Electronics. “Since acquiring HARMAN in 2017, the company has scaled its automotive and audio business from $7 billion to more than $11 billion today. Adding ZF’s ADAS capabilities builds on that momentum. HARMAN will further expand its technology foundation to deliver safer, more intelligent, and more intuitive in-vehicle experiences. This acquisition reinforces HARMAN’s leadership in the industry’s transformation and underscores Samsung’s long term commitment to the future of mobility.”
“This transaction marks a major milestone in the execution of HARMAN’s long-term strategy and further strengthens our portfolio,” said Carolin Reichert, Chief Strategy Officer of HARMAN. “Throughout the process, we worked in a very constructive collaboration with ZF and demonstrated our ability to successfully execute a highly complex carve-out.”
As part of the agreement, approximately 3,750 ZF employees across Europe, the Americas and Asia are expected to transition to HARMAN upon closing of the transaction. The transaction is expected to close in the second half of 2026, subject to receiving necessary regulatory approvals.
Upon closing, HARMAN will integrate ZF’s ADAS capabilities into its centralized compute and digital cockpit roadmap, enabling OEMs to deploy more scalable, safety-integrated vehicle architectures. The companies will maintain strong support for existing programs while aligning engineering, ADAS and compute teams to accelerate innovation for next-generation platforms.
About HARMAN
HARMAN is a global leader in Lifestyle Audio and Automotive technology. We create intelligent experiences that enrich people’s lives on the road, in their homes, on the stage, and everywhere in between. Our iconic audio brands — including JBL®, Harman Kardon®, AKG®, Bowers & Wilkins®, Denon®, and Marantz® — bring premium sound to consumers and audio/visual professionals worldwide. More than 50 million vehicles globally rely on HARMAN’s technologies to deliver safer, smarter, and more intuitive in-cabin experiences. A wholly owned subsidiary of Samsung Electronics Co., Ltd., HARMAN has approximately 26,000 employees around the world.
About ZF
ZF is a global technology company supplying advanced mobility products and systems for passenger cars, commercial vehicles and industrial technology. Its comprehensive product range is primarily aimed at vehicle manufacturers, mobility providers and start-up companies in the fields of transportation and mobility. ZF electrifies a wide range of vehicle types. With its products, the company contributes to reducing emissions, protecting the climate as well as enhancing safe mobility. Alongside the automotive sector – passenger cars and commercial vehicles – ZF also serves market segments such as construction and agricultural machinery, wind power, marine propulsion, rail drives and test systems. With some 161,600 employees worldwide, ZF reported sales of €41.4 billion in fiscal 2024. The company operates 161 production locations in 30 countries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251223683768/en/
Contacts
Media:
HARMAN
Dawn Geary
Director, Global Communications, Automotive
dawn.geary@harman.com
ZF Group
Mirko Gutemann
Spokesman Corporate R&D, ADAS/AD Technology, Safety Technology
mirko.gutemann@zf.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom